JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2018-03-31 hypo2012

审稿速度:6.0 | 投稿命中率:25.0
经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。

438 0

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2018-02-16 bolt614

审稿速度:6.0 | 投稿命中率:25.0
经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。

395 0

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2017-12-28 tuodi1986xjtu

审稿速度:2.0 | 投稿命中率:25.0
经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。

325 0

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2017-12-16 qxmao

胸心外科顶级杂志，审稿相当严格，original article相当难发

300 0

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2017-08-20 coldmountainwang

审稿速度:2.0 | 投稿命中率:50.0
经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了

366 0

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2017-08-06 tuodi1986xjtu

审稿速度:1.0 | 投稿命中率:25.0
经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。

446 0

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2016-09-06 jyzxjiangqin

希望能有好消息！

349 0

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2016-08-22 ms1997812597079028

审稿速度:1.0
经验分享：审稿速度很快！
一周就出结果了！2周就得修回！
还要制作video ！

36 0

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2016-04-10 hypo2012

审稿神速！一周就出结果了！2周就得修回！还要制作Video ！

361 0

[GetPortalCommentsPageByObjectIdResponse(id=554369, encodeId=d747554369bb, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该杂志审稿的确非常严格，审稿人提的问题相当多，尤其是统计学方面（2个统计学专家不但提统计学问题还会提很多临床问题）。本人最近有幸中了2篇Original Article，都中的很艰辛，一篇修了3次（4月-10月），另一篇修了2次（去年11月-今年3月）。一审还是比较快的，修回后等待会比较漫长。个人感觉还是ATS比较友好，最近发的3篇Original Article不到3个月就接受了（一审修回后编辑直接接受）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=438, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sat Mar 31 14:56:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552715, encodeId=e8ba552e154b, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：2017年有幸被JTCVS接受2篇original article，过程很艰辛，一篇5个审稿人，另一篇6个审稿人。问题很细致，等待时间也很漫长，但最终还是获得了好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Fri Feb 16 22:08:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550410, encodeId=c06e55041047, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我们团队近期从JTCVS的官网上统计了一下，2015年1月-2017年12月3年间，大陆在上面发了12篇文章（包括2篇个案），且大部分是关于肺癌的手术文章，平均一年仅有4篇，确实弥足珍贵啊！其中肺科医院的姜格宁和北大人民医院的王俊各3篇，复旦肿瘤的陈海泉2篇，广医附院何建行1篇，唐都医院李小飞1篇，浙大一院胡坚1篇，福医一院陈剑锋1篇，基本全是行业内大佬级别的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Thu Dec 28 09:00:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550053, encodeId=7599550053ae, content=胸心外科顶级杂志，审稿相当严格，original article相当难发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2dc91627271, createdName=qxmao, createdTime=Sat Dec 16 05:37:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545707, encodeId=0aea545e079a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：前几天刚中了一篇，JTCVS现在越来越慢了，修回去半个月编辑才会处理，可能跨过了4分这个坎，越来越严格了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep0STShykic9Rgs5u0T4bCjKM9flJykzykyjrLg4NMYcdnTsDBHDTwYB5oArAuWJjtUwS3BD1WicEWA/132, createdBy=32bd1667592, createdName=coldmountainwang, createdTime=Sun Aug 20 20:34:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545193, encodeId=4806545193f1, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年发了一篇surgical technology，当时一审1个月就出了结果，修回后1月就接收了。最近又投了一篇，20天左右才给分配了稿号，但我看已经到1400多了，看了这个杂志稿源很好，毕竟是胸心外科的第一期刊。如果按照这个速度，年收稿量在2800左右，年发文章280篇，文章接收率就在10%。还是希望这个期刊越来越来，行业内开学术会议时，展示的成果能发表在JTCVS上还是很受到同行认可的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=446, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Sun Aug 06 23:27:00 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526829, encodeId=df7d5268293b, content=希望能有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Sep 06 06:26:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833279, encodeId=4a408332e998, content=审稿速度:1.0 经验分享：审稿速度很快！ 一周就出结果了！2周就得修回！ 还要制作video ！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a345414032, createdName=ms1997812597079028, createdTime=Mon Aug 22 11:27:31 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=521149, encodeId=914052114901, content=审稿神速！一周就出结果了！2周就得修回！还要制作Video ！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e25f57702, createdName=hypo2012, createdTime=Sun Apr 10 15:31:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518730, encodeId=53b4518e30c3, content=我刚刚投了一篇，来此报道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab3d1683056, createdName=Dr.Animosity, createdTime=Sun Jan 24 20:18:00 CST 2016, time=2016-01-24, status=1, ipAttribution=)]

2016-01-24 Dr.Animosity

我刚刚投了一篇，来此报道

383 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务